News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
29,174 Results
Type
Article (3435)
Company Profile (5)
Press Release (25734)
Section
Business (8285)
Career Advice (34)
Deals (992)
Drug Delivery (4)
Drug Development (4741)
Employer Resources (3)
FDA (849)
Job Trends (841)
News (14667)
Policy (1196)
Tag
Academia (370)
Alliances (2024)
Alzheimer's disease (78)
Antibody-drug conjugate (ADC) (6)
Approvals (851)
Bankruptcy (9)
Best Places to Work (757)
Bladder cancer (6)
Breast cancer (19)
Cancer (102)
Cardiovascular disease (6)
Career advice (33)
Cell therapy (15)
Clinical research (3903)
Collaboration (24)
COVID-19 (124)
C-suite (14)
Cystic fibrosis (10)
Data (113)
Diabetes (9)
Diagnostics (223)
Drug pricing (7)
Earnings (1957)
Events (3948)
Executive appointments (31)
FDA (887)
Funding (33)
GLP-1 (28)
Government (142)
Healthcare (829)
Immunology and inflammation (10)
Infectious disease (127)
Inflammatory bowel disease (48)
IPO (438)
Job creations (122)
Job search strategy (32)
Layoffs (5)
Legal (186)
Lung cancer (11)
Lymphoma (10)
Manufacturing (7)
Medical device (454)
Medtech (454)
Mergers & acquisitions (558)
Metabolic disorders (14)
Multiple sclerosis (6)
Neurodegenerative disease (7)
Neuroscience (97)
NextGen: Class of 2025 (301)
Non-profit (334)
Northern California (108)
Obesity (6)
People (3772)
Phase I (1079)
Phase II (1669)
Phase III (1522)
Pipeline (39)
Postmarket research (172)
Preclinical (398)
Press Release (6)
Radiopharmaceuticals (17)
Rare diseases (14)
Real estate (193)
Regulatory (944)
Research institute (217)
Series A (10)
Southern California (104)
Startups (206)
United States (748)
Vaccines (22)
Date
Today (6)
Last 7 days (32)
Last 30 days (106)
Last 365 days (1567)
2025 (106)
2024 (1595)
2023 (1973)
2022 (3206)
2021 (2573)
2020 (2277)
2019 (2206)
2018 (1648)
2017 (1626)
2016 (1613)
2015 (1753)
2014 (1302)
2013 (984)
2012 (981)
2011 (1047)
2010 (874)
Location
Africa (35)
Arizona (9)
Asia (1120)
Australia (214)
California (255)
Canada (54)
China (15)
Colorado (10)
Connecticut (6)
Delaware (9)
Europe (4428)
Florida (20)
Georgia (17)
Illinois (23)
Indiana (10)
Japan (8)
Maryland (13)
Massachusetts (109)
Michigan (12)
New Jersey (76)
New York (72)
North Carolina (20)
Northern California (108)
Ohio (20)
Pennsylvania (23)
South America (33)
Southern California (104)
Texas (19)
Utah (6)
Washington State (15)
29,174 Results for "uc davis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
Femasys Inc. today announced that it has activated enrollment for its pivotal FemBloc® trial at University of California, Davis (“UC Davis”) Medical Center in Sacramento, California.
January 26, 2024
·
7 min read
Lone Star Bio
The Caris Precision Oncology Alliance Welcomes UC Davis Comprehensive Cancer Center
Caris Life Sciences®, the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition, announced that UC Davis Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™.
August 17, 2023
·
5 min read
Press Releases
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn’s Disease and Ulcerative Colitis (UC)
November 21, 2024
·
6 min read
Press Releases
Palisade Bio Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis (UC)
November 7, 2024
·
5 min read
Press Releases
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA
October 23, 2024
·
6 min read
Press Releases
Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)
October 10, 2024
·
6 min read
Press Releases
Myriad Genetics Expands Board of Directors with Election of Mark S. Davis as New Board Member
December 11, 2024
·
3 min read
Press Releases
Lilly Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for OMVOH® (mirikizumab) for adults with moderately to severely active ulcerative colitis (UC)
September 3, 2024
·
4 min read
Deals
Probo Medical Completes Acquisition of Davis Medical
Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced the acquisition of Davis Medical Electronics, Inc. (“Davis Medical”).
November 16, 2023
·
2 min read
Press Releases
Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
September 26, 2024
·
7 min read
1 of 2,918
Next
